About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
The Bottom Line
- First classify by acuity and stability: seconds-minutes suggests PE, pneumothorax, anaphylaxis, aspiration, arrhythmia; days suggests pneumonia, asthma/COPD exacerbation, HF; months suggests COPD, ILD, anaemia, HF, deconditioning, anxiety
- Immediate danger signs: inability to speak, altered mental status, cyanosis, silent chest, hypotension, SpO2 <90%, exhaustion, or rising CO2
- All significant acute dyspnoea needs ABCs, vitals, pulse oximetry, focused cardiorespiratory exam, ECG, CXR, and targeted labs; ABG/VBG if severe or hypercapnia suspected
- The exam favours structured branches: airway obstruction, parenchymal lung disease, pleural disease, pulmonary vascular disease, cardiac disease, blood/neuromuscular/metabolic causes
- Do not reassure a patient with normal oxygen saturation if there are red flags — early PE, metabolic acidosis, anaemia, anxiety, and neuromuscular weakness can have preserved SpO2
Approach to the Presentation
Dyspnoea is one of the highest-yield MCCQE1 presentations because it crosses emergency medicine, family medicine, internal medicine, paediatrics, psychiatry, and palliative care. The first decision is not the diagnosis — it is whether the patient is critically ill. Assess airway patency, work of breathing, oxygenation, circulation, mental status, and ability to speak. Once stabilisation is underway, use onset, triggers, associated symptoms, past cardiorespiratory disease, medication exposure, thromboembolic risk, occupational exposure, and smoking/vaping history to build the differential. Acute dyspnoea is dangerous until proven otherwise; chronic dyspnoea is approached through spirometry, CXR, CBC, BNP/NT-proBNP, ECG, and targeted cardiopulmonary testing.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Pulmonary Embolism | must-not-miss | Acute dyspnoea, pleuritic chest pain, tachycardia, hypoxia, syncope or haemoptysis. Risk factors: recent surgery/immobility, malignancy, pregnancy/postpartum, estrogen therapy, prior VTE | Wells score or YEARS/PERC pathway + D-dimer if low/intermediate risk; CTPA if high risk or positive D-dimer |
| Tension Pneumothorax | must-not-miss | Sudden dyspnoea and pleuritic pain, hypotension, tachycardia, unilateral absent breath sounds, hyperresonance, tracheal deviation late. Risk: trauma, COPD, mechanical ventilation | Clinical diagnosis — immediate decompression before imaging if unstable |
| Anaphylaxis / Upper Airway Angio-oedema | must-not-miss | Dyspnoea with urticaria, flushing, hypotension, wheeze, stridor, tongue/lip swelling, GI symptoms after food, drug, insect sting, or allergen exposure | Clinical diagnosis; do not wait for tests. Serum tryptase can support later but never delays epinephrine |
| Severe Asthma or COPD Exacerbation | must-not-miss | Wheeze, cough, increased work of breathing, accessory muscle use, inability to speak. COPD often has sputum change; asthma may have triggers/allergens and variable symptoms | Clinical severity + peak flow/spirometry when safe; VBG/ABG for CO2 retention or impending failure |
| Acute Decompensated Heart Failure / Pulmonary Oedema | must-not-miss | Orthopnoea, PND, crackles, elevated JVP, S3, peripheral oedema, hypertension or ACS trigger; pink frothy sputum in severe cases | BNP/NT-proBNP, CXR pulmonary oedema, ECG, troponin, bedside lung/cardiac ultrasound, echocardiography |
| Pneumonia / Sepsis | common | Fever, cough, sputum, pleuritic pain, focal crackles, delirium in older adults. May present with hypoxia and tachypnoea before fever | CXR consolidation + CBC, CRP if used locally, blood cultures if severe, sputum culture if admitted or severe |
| Anaemia | common | Exertional dyspnoea, fatigue, pallor, tachycardia, normal lung exam and SpO2. Menorrhagia, GI bleeding, CKD, pregnancy, malignancy risk | CBC, ferritin/iron studies, B12/folate as indicated, stool testing/endoscopy if occult GI loss suspected |
| Panic Attack / Anxiety | common | Dyspnoea with chest tightness, paresthesias, trembling, fear, hyperventilation, normal exam and oxygenation. Diagnosis of exclusion when red flags absent | Clinical after excluding dangerous cardiopulmonary causes based on history, exam, ECG/CXR/labs when indicated |
| Interstitial Lung Disease | less common | Progressive exertional dyspnoea, dry cough, bibasal fine inspiratory crackles, clubbing. Exposures: birds, mould, asbestos, silica; autoimmune symptoms | CXR/HRCT, restrictive PFTs with low DLCO, autoimmune serology if indicated |
| Metabolic Acidosis / Sepsis / DKA | less common | Air hunger or Kussmaul breathing, tachypnoea with clear lungs, dehydration, abdominal pain, diabetes, renal failure, toxin exposure | VBG/ABG, glucose/ketones, lactate, electrolytes, anion gap, renal function |
Red Flags & Key History
Symptoms
Sudden onset dyspnoea with pleuritic pain, syncope, or haemoptysis — PE or pneumothorax until proven otherwise
Inability to speak full sentences, exhaustion, drowsiness, or confusion — impending respiratory failure
Stridor, voice change, drooling, facial/tongue swelling — upper airway emergency
Orthopnoea and PND — supports cardiac failure but may coexist with respiratory disease
Fever, rigors, purulent sputum, pleuritic pain — infection, pneumonia, or empyema
Weight loss, night sweats, TB exposure, immigration from high-prevalence area, incarceration, shelter exposure — TB or malignancy
Occupational exposures (asbestos, silica, birds, mould, mining, welding) — chronic lung disease or malignancy
Signs
SpO2 <90%, cyanosis, silent chest, or altered mental status
Unilateral absent breath sounds or hyperresonance
Elevated JVP, S3, peripheral oedema — heart failure or pulmonary hypertension
Tracheal deviation, hypotension, distended neck veins — tension pneumothorax
Fine end-inspiratory bibasal crackles and clubbing — interstitial lung disease
Respiratory rate is often the earliest abnormal vital sign; marked tachypnoea with clear lungs suggests PE, metabolic acidosis, sepsis, or anxiety
Approach to Investigation
First-line
Pulse oximetry + full vital signsAssess severity and trend. Remember: normal SpO2 does not exclude PE, anaemia, metabolic acidosis, early asthma/COPD, or anxiety
12-lead ECGACS, arrhythmia, RV strain from PE, prior MI, LVH. Dyspnoea can be an ACS equivalent in older adults, women, and patients with diabetes
CXRPneumonia, pneumothorax, pulmonary oedema, pleural effusion, mass, hyperinflation, ILD, cardiomegaly. Portable CXR if unstable
CBC, electrolytes/creatinine, glucoseAnaemia, infection, renal failure, metabolic contributors. Add lactate if sepsis or shock suspected
Second-line
VBG/ABGIf severe distress, altered mental status, hypoxia, suspected hypercapnia, metabolic acidosis, or failure to improve. COPD exacerbation: pH and PaCO2 guide non-invasive ventilation
BNP/NT-proBNP + troponinBNP supports/rules out heart failure in undifferentiated dyspnoea; troponin if ACS, myocarditis, PE strain, or demand ischaemia suspected
D-dimer / CTPAUse only through a pre-test probability pathway. Do not order D-dimer in high-risk patients — proceed to imaging if stable
Spirometry with bronchodilator responseFor chronic or recurrent dyspnoea after acute instability is excluded; confirms asthma/COPD and grades obstruction
Bedside ultrasoundLung B-lines (pulmonary oedema), absent lung sliding (pneumothorax), pleural effusion, cardiac function, RV dilation, IVC assessment
Specialist
EchocardiographyIf suspected HF, valvular disease, pulmonary hypertension, unexplained dyspnoea, or abnormal BNP/ECG
HRCT chest + full PFTs including DLCOFor suspected ILD, occupational lung disease, unexplained restrictive pattern, or persistent abnormal CXR
Cardiopulmonary exercise testingFor persistent unexplained exertional dyspnoea after cardiac, respiratory, haematologic, and metabolic workup
Management Principles
Canadian Thoracic Society guidance + CAEP emergency approach + Choosing Wisely Canada1
Immediate stabilisation
- ABCs, call for help if unstable, sit upright, continuous monitoring, IV access, oxygen titrated to target saturation
- Target SpO2 92-96% for most acutely ill adults; 88-92% if known/suspected chronic CO2 retention (COPD, obesity hypoventilation, neuromuscular disease)
- Treat immediately reversible threats: epinephrine for anaphylaxis, bronchodilators for bronchospasm, decompression for tension pneumothorax, non-invasive ventilation for acute hypercapnic COPD or cardiogenic pulmonary oedema
2
Syndrome-directed initial treatment
- Wheeze/bronchospasm: inhaled salbutamol + ipratropium for moderate-severe exacerbation, systemic corticosteroid, magnesium sulfate if severe asthma
- Pneumonia/sepsis: empiric antibiotics guided by severity and local antibiogram, fluids/vasopressors if septic shock, oxygen and admission if hypoxic or high risk
- Heart failure: nitrates if hypertensive pulmonary oedema, IV furosemide if volume overloaded, non-invasive ventilation if severe distress
- PE: anticoagulation once suspected and bleeding risk acceptable; thrombolysis or catheter/surgical therapy for massive PE with shock
3
Chronic dyspnoea pathway
- Confirm obstructive disease with spirometry before long-term inhaler escalation whenever feasible
- Smoking cessation, vaccination, pulmonary rehabilitation, exercise conditioning, and occupational exposure reduction are core Canadian primary care interventions
- Avoid low-value testing: do not repeat CXR or CT without a clinical question; do not use antibiotics for uncomplicated viral respiratory infections
Complications & Pitfalls
- Normal oxygen saturation trap: PE, anaemia, metabolic acidosis, and early asthma can be serious despite normal SpO2.
- Delayed airway escalation: Drowsiness, silent chest, exhaustion, or rising PaCO2 means the patient is tiring — do not wait for arrest.
- D-dimer overuse: D-dimer is useful only when pre-test probability is low/intermediate; indiscriminate testing creates false positives and unnecessary CT.
- Anchoring on anxiety: Panic is common, but it is a diagnosis made after red flags and dangerous causes have been considered.
- Missing cardiac dyspnoea: Dyspnoea may be the presenting symptom of ACS or heart failure, particularly in older adults and patients with diabetes.
MCCQE1 Exam Tips
- 1The MCC objective is presentation-based: the first answer is often stabilise and classify severity, not name a final diagnosis
- 2Sudden pleuritic dyspnoea + tachycardia = think PE or pneumothorax. Add hypotension or unilateral absent breath sounds = treat tension pneumothorax clinically
- 3Dyspnoea with wheeze is not always asthma — cardiac asthma, anaphylaxis, foreign body, COPD, and PE can all wheeze
- 4For chronic dyspnoea, spirometry is the key first-line test for asthma/COPD; HRCT is not first unless CXR/PFTs suggest ILD or malignancy
- 5Use Canadian oxygen targets: most patients 92-96%; CO2 retainers 88-92%
- 6In a COPD exacerbation with pH <7.35 and elevated CO2, the next best step is non-invasive ventilation unless contraindicated
- 7CanMEDS communicator point: explain uncertainty and safety-net clearly — worsening breathlessness, chest pain, syncope, cyanosis, or inability to speak warrants urgent reassessment
practicetest your knowledge on dyspnoeaApply what you've learnt with MCCQE1-style questions from the iatroX Q-Bank — respiratory and beyond.
open q-bank